Illinois Pain Institute is categorized under Dental Laboratories in Mchenry, IL and active since 2010.
Illinois Pain Institute was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Dental Laboratories business, which does work in the B2C market, and is classified as a Dental Laboratories, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 4309 West Medical Center Drive # B103, Mchenry, Illinois IL 60050 or by phoning (815) 363-9595. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Illinois Pain Institute |
| Address: | 4309 West Medical Center Drive # B103, Mchenry, Illinois 60050 |
| Phone Number: | (815) 363-9595 |
| Website Address: | illinoisdentalinstitute.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Dental Laboratories |
| SIC Code: | 8072 |
| NAICS Code: | 6211110 |
| Share This Business: |
Illinois Pain Institute was started in 2010 to provide professional Dental Laboratories under the SIC code 8072 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact for inquiries that concern Illinois Pain Institute by calling the company number (815) 363-9595, as your correspondence is most welcome. Additionally, the physical location of the single location of Illinois Pain Institute can be found at the coordinates 42.318564,-88.284257 as well as the street address 4309 West Medical Center Drive # B103 in Mchenry, Illinois 60050.
For its online presence, you may visit Illinois Pain Institute’s website at illinoisdentalinstitute.com and engage with its social media outlets through on Twitter and on Facebook.